© Globe Newswire
02.12.2024
KDEV
LISTED
STO
Karolinska Development implements organizational changes for more efficient portfolio management
News Preview
STOCKHOLM, SWEDEN – December 2, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the company has decided to implement organizational changes in order to reduce the cost base of its operations. The changes involve reducing the management team by one person and giving notice of redundancy to a total of three employees. Th...
Themefolio
Profiler
Peergroup
© EQS Newswire
02.12.2024
GXI
LISTED
XETR
Gerresheimer builds new production capacities for glass syringes at Skopje site
News Preview
Gerresheimer builds new production capacities for glass syringes at Skopje site
Expansion of the site in the Republic of North Macedonia with a new production hall for glass syringes
Total investment volume of over EUR 100 million
Around 250 new jobs for skilled workers from the region
Ramp-up of syringe production starting by the end of 2024
......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.12.2024
GXI
LISTED
XETR
Gerresheimer baut am Standort Skopje neue Produktionskapazitäten für Glasspritzen auf
News Preview
Gerresheimer baut am Standort Skopje neue Produktionskapazitäten für Glasspritzen auf
Erweiterung des Standortes in der Republik Nordmazedonien um neue Produktionshalle für Glasspritzen
Gesamtinvestitionsvolumen von über 100 Mio. Euro
Rund 250 neue Arbeitsplätze für Fachkräfte aus der Region
Anlauf der Spritzenproduktion ab Ende 2024
Düsseld......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
02.12.2024
ZLAB
LISTED
NASDAQ
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
News Preview
Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced today that the pivotal, Phase 3 PANOVA-3 trial met its primary endpoint, demonstrating a statistically significant improvement in median overall survival (mOS) versus control. PANOVA-3 evaluated the use of Tumor Treating Fields (TTFields) therapy concomitantly with ge...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
02.12.2024
DFTX
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to four newly hired non-executive employees consisting of options to purchase an aggregate of 171,000 common shar...
Themefolio
Profiler
Peergroup
© EQS Newswire
02.12.2024
EUZ
LISTED
XETR
Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply
News Preview
Berlin, 02 December 2024. Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) today celebrates the successful start of Actinium-225 (Ac-225) production, addressing the global shortage of this critical radionuclide. This milestone marks a major success of the common project with the Nuclear Physics Institute of the Czech Academy of Sciences......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.12.2024
EUZ
LISTED
XETR
Eckert & Ziegler startet Produktion von Actinium-225 und ebnet den Weg für die Versorgung mit GMP-Material
News Preview
Berlin, 02. Dezember 2024. Die Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) feiert heute den erfolgreichen Start der Produktion von Actinium-225 (Ac-225) und begegnet damit dem weltweiten Mangel an diesem wichtigen Radionuklid. Dieser Meilenstein ist ein enormer Erfolg für das gemeinsame Projekt mit dem Institut für Kernphysik der A......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
01.12.2024
AGFB
LISTED
EURONEXT
At RSNA 2024, AGFA HealthCare Presents RUBEE(R) AI Powered by CARPL Platform
News Preview
Bringing yet another clinical breakthrough to the 2024 RSNA Annual Meeting, AGFA HealthCare is excited to announce a new partnership with CARPL.ai - the world's largest radiology AI marketplace. MORTSEL, BE / ACCESSWIRE / December 1, 2024 / In Chicago, AGFA HealthCare is set to demonstrate the seamless integration of CARPL.ai into AGFA HealthCare E...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2024
BAVA
LISTED
CPH
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
News Preview
COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© PR Newswire
29.11.2024
RAY B
LISTED
STO
RaySearch Laboratories to present ongoing development in liver ablation therapy* at RSNA 2024
News Preview
STOCKHOLM, Nov. 29, 2024 /PRNewswire/ -- RaySearch will be exhibiting its advanced software solutions at RSNA in Chicago, Illinois, December 1 – 4. RSNA is the largest conference show in the field of radiology which opens new horizons for the company. Participants can book demonstrations of the module, which is ongoing development, for liver abla...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2024
BAVA
LISTED
CPH
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
News Preview
COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 218,750 as a consequence of employees’ exercise of warrants....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
29.11.2024
EVT
LISTED
XETR
Evotec announces change in Management Board
News Preview
Dr Craig Johnstone steps down as Chief Operating Officer effective 31 December 2024
Distribution of responsibilities internally
Hamburg, Germany, 29 November 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr Craig Johnstone, will step down and leave th......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.11.2024
EVT
LISTED
XETR
Evotec gibt Veränderung im Vorstand bekannt
News Preview
Dr. Craig Johnstone tritt mit Wirkung zum 31. Dezember 2024 als Chief Operating Officer zurück
Verantwortlichkeiten werden intern verteilt
Hamburg, 29 November 2024:
Die Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute bekannt, dass ihr Chief Operating Officer, Dr. Craig Johnstone, Evotec mit Wir......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
29.11.2024
EVT
LISTED
XETR
Evotec Announces Change in Management Board
News Preview
Dr Craig Johnstone steps down as Chief OperatingOfficer effective 31 December 2024Distribution of responsibilities internally HAMBURG, GERMANY / ACCESSWIRE / November 29, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr Craig Johnstone, will step down...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
IMMNOV
LISTED
STO
Immunovia to present at the Redeye Technology & Life Science Day
News Preview
LUND, Sweden, Nov. 28, 2024 /PRNewswire/ -- Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, will present at the Redeye Technology & Life Science Day on December 3, hosted by Redeye.
Redeye Technology & Life Science Day gathers over 40 leading Nordic companies for a live-streamed event to showcase the groundbreaking wo...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
INTEG B
LISTED
STO
Integrum Launches Service Initiative to Strengthen U.S. Market Growth
News Preview
MÖLNDAL, Sweden, Nov. 28, 2024 /PRNewswire/ -- Integrum AB (publ), ticker (STO: INTEG), a leader in medical technology and developer of the bone-anchored OPRA® Implant System, announces the launch of a new service initiative to enhance warranty and service support for its Axor™ II devices. This initiative is a critical step in advancing Integrum'...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
SECT_B
LISTED
STO
Invitation to presentation of Sectra's six-month interim report 2024/2025 and date for CMD
News Preview
LINKÖPING, Sweden, Nov. 28, 2024 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) invites investors, analysts, and the media to a presentation of the company's six-month report with President Torbjörn Kronander and CFO Jessica Holmquist. Sectra will also hold a Capital Markets Day (CMD) on March 27,...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
SECT_B
LISTED
STO
Belgian hospital chooses Sectra's enterprise imaging solution to support faster radiology diagnostics for better patient care
News Preview
LINKÖPING, Sweden, Nov. 28, 2024 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide AZ Sint-Lucas Gent in Belgium with its enterprise imaging solution. The solution will allow radiologists to complete the entire diagnostic process within a single application, with all necessary tools easil...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.11.2024
FYB
LISTED
XETR
Formycon berichtet Neunmonatsergebnis 2024 und setzt Wachstumskurs mit weiteren operativen Erfolgen fort
News Preview
Pressemitteilung // 28. November 2024
Formycon berichtet Neunmonatsergebnis 2024 und setzt Wachstumskurs mit weiteren operativen Erfolgen fort
Hervorragendes drittes Quartal mit Produktzulassungen für FYB202 in den Schlüsselmärkten USA und Europa
Keytruda®-Biosimilar-Kandidat FYB206 startet klinisches Entwicklungsprogramm (Phase I und Phase I......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.11.2024
FYB
LISTED
XETR
Formycon reports nine-month results for 2024 and continues growth trajectory with further operational successes
News Preview
Press Release // November 28, 2024
Formycon reports nine-month results for 2024 and continues growth trajectory with further operational success
Excellent third quarter with product approvals for FYB202 in the key markets USA and Europe
Keytruda® biosimilar candidate FYB206 starts clinical development program (phase I and phase III study)
Dev......
Themefolio
Profiler
Peergroup
© BusinessWire
28.11.2024
ZLAB
LISTED
NASDAQ
Zai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2024 National Reimbursement Drug List (NRDL) released by China’s National Healthcare Security Administration (NHSA) has been updated to include the following medicines and indications:
AUGTYRO® (repotrectinib) is included in the NRDL for the treatment of adult patients with loc...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
BIOA B
LISTED
STO
Leqembi® launched in South Korea
News Preview
STOCKHOLM, Nov. 28, 2024 /PRNewswire/ - BioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult patients with mild cognitive impairment due to Alzheimer's disease (AD) o...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
BIOA B
LISTED
STO
Leqembi® launched in South Korea
News Preview
STOCKHOLM, Nov. 27, 2024 /PRNewswire/ - BioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult patients with mild cognitive impairment due to Alzheimer's disease (AD) o...
Themefolio
Profiler
Peergroup
© BusinessWire
27.11.2024
ICLR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
News Preview
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your Icon investments or would like...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2024
QGEN
LISTED
NYSE
QIAGEN führt neuartige Tools zur Anpassung von digitalen PCR‑Assays und NGS-Panels für die mikrobielle Analyse ein
News Preview
QIAGEN führt das erste Design-Tool für individuell anpassbare digitale PCR-Assays im Markt ein, ausgestattet mit fortschrittlichen Design-Algorithmen für verschiedene mikrobielle Anwendungen und kundenspezifische NGS-Panels // Erstes Custom Assay Design Tool für mikrobielle dPCR-Assays bietet hohe Flexibilität in der digitalen PCR-Analyse von bakte...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2024
IMMNOV
LISTED
STO
Immunovia Publishes Interim Report for January-September 2024
News Preview
LUND, Sweden, Nov. 27, 2024 /PRNewswire/ --
July-September 2024
Net sales, which for the quarter only included royalties, amounted to 235 KSEK (488).Net earnings amounted to -51.1 MSEK (-38.6).Earnings per share before and after dilution were -0.73 SEK (-0.91).Cash flow from operating activities amounted to -21.2 MSEK (-35.6).Cash and cash equi...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.11.2024
EUZ
LISTED
XETR
Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a)
News Preview
Berlin, 27 November 2024. Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) today received approval of its proprietary non-carrier added Lutetium-177 chloride, Theralugand®, by the European Commission (EC). This enables the use of the radiopharmaceutical medicinal product Theralugand® in routine clinical applications throughout the Europ......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.11.2024
EUZ
LISTED
XETR
Eckert & Ziegler erhält europäische Zulassung für Theralugand® - Lutetium-177 Chlorid (n.c.a)
News Preview
Berlin, 27. November 2024. Die Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) hat die Zulassung für ihr trägerfreies Lutetium-177-Chlorid, Theralugand®, durch die Europäische Kommission (EK) erhalten. Damit kann das Radiopharmazeutikum Theralugand® nun routinemäßig für klinische Anwendungen im gesamten Europäischen Wirtschaftsraum (EW......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
27.11.2024
AGFB
LISTED
EURONEXT
Self Regional Healthcare Brings Future-Ready Enterprise Imaging Cloud Technology Into South Carolina With AGFA Healthcare
News Preview
Self Regional Healthcare aims to upgrade its PACS, enhance diagnostic imaging capabilities, and strengthen its financial position while optimizing staff workflows. By adopting AGFA HealthCare's Enterprise Imaging Cloud, they are poised to successfully achieve these objectives. MORTSEL, BE / ACCESSWIRE / November 27, 2024 / In a significant leap for...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2024
IMMNOV
LISTED
STO
Immunovia Publishes Interim Report for January-September 2024
News Preview
LUND, Sweden, Nov. 27, 2024 /PRNewswire/ --
July-September 2024
Net sales, which for the quarter only included royalties, amounted to 235 KSEK (488).Net earnings amounted to -51.1 MSEK (-38.6).Earnings per share before and after dilution were -0.73 SEK (-0.91).Cash flow from operating activities amounted to -21.2 MSEK (-35.6).Cash and cash equi...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2024
ORNBV
LISTED
HEL
142,701 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE27 NOVEMBER 2024 at 9.00 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2024
ICLR
LISTED
NASDAQ
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
News Preview
Law Offices of Howard G. Smith continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of federal securities laws.
On October 23, 2024, Icon released its third quarter 2024 financial results, missing consensus estimates “due to specific c...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2024
FAGR
LISTED
EURONEXT
Disclosure of notification received from FMR LLC
News Preview
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 November 2024 – 6.45 PM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
ICLR
LISTED
NASDAQ
The Law Offices of Frank R. Cruz Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
News Preview
The Law Offices of Frank R. Cruz continues its investigation of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On October 23, 2024, Icon released its thir...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.11.2024
GMAB
LISTED
CPH
Genmab to Present at Citi’s Global Healthcare Conference
News Preview
Media ReleaseCOPENHAGEN, Denmark; November 25, 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
TEM
LISTED
NASDAQ
Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, held in New York, New York.
Tempus Founder and CEO, Eric Lefkofsky, will participate in a fireside discussion at the c...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
ERF
LISTED
EURONEXT
Eurofins Sustainability Services Introduces CleanAir Check Service for Volatile Organic Compounds (VOCS) Testing
News Preview
Eurofins Sustainability Services, a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include a CleanAir Check service that tests for Volatile Organic Compounds (VOCs). Given that VOCs pose significant concerns for human health and the environment, increasingly stringen...
Themefolio
Profiler
Peergroup
© PR Newswire
25.11.2024
SECT_B
LISTED
STO
French hospital joins regional pathology solution from Sectra to enhance collaboration and speed up cancer diagnostics
News Preview
LINKÖPING, Sweden, Nov. 25, 2024 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra's (STO: SECT B) digital pathology solution will be adopted by the hospital CH Béziers in France. They are the third hospital in the region to choose Sectra, providing them with a powerful platform for collaboration. The solution will...
Themefolio
Profiler
Peergroup
© EQS Newswire
22.11.2024
EVT
LISTED
XETR
Comment on withdrawn non-binding offer
News Preview
Ad hoc: Comment on withdrawn non-binding offer
Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO)
Evotec SE has taken notice of the statement made by Halozyme Therapeutics Inc. on 22 November, stating that it has withdrawn its non-binding proposal to acquire Ev......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.11.2024
EVT
LISTED
XETR
Kommentar zum Rückzug eines unverbindlichen Angebots
News Preview
Ad hoc: Kommentar zum Rückzug eines unverbindlichen Angebots
Hamburg – Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO)
Die Evotec SE hat die Erklärung der Halozyme Therapeutics Inc. vom 22. November 2024 zur Kenntnis genommen, wonach diese ihr unverbindliches Angebot zur Üb......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.11.2024
EUZ
LISTED
XETR
Eckert & Ziegler erhöht erneut die Prognose für das laufende Geschäftsjahr
News Preview
Eckert & Ziegler erhöht erneut die Prognose für das laufende Geschäftsjahr.Jahresprognose 2024:
Umsatz von etwa 290 Mio. EUR (angehoben)
EBIT vor Sondereinflüssen von rund 60 Mio. EUR (angehoben)
Berlin, 22.11.2024 Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) erhöht erneut die Jahresprognose für das laufende Geschäftsjahr. Auf Basi......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.11.2024
EUZ
LISTED
XETR
Eckert & Ziegler raises its forecast for the current financial year once again
News Preview
Eckert & Ziegler raises its forecast for the current financial year once again.Forecast for 2024:
Sales of around EUR 290 million (raised)
EBIT before special items of around EUR 60 million (raised)
Berlin, 22 November 2024 Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) is once again raising its annual forecast for the current financial ......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
22.11.2024
EVT
LISTED
XETR
Comment on Withdrawn Non-Binding Offer
News Preview
HAMBURG, GERMANY / ACCESSWIRE / November 22, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480)(NASDAQ:EVO)Evotec SE has taken notice of the statement made by Halozyme Therapeutics Inc. on 22 November, stating that it has withdrawn its non-binding proposal to acquire Evotec SE (NASDAQ:EVO...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.11.2024
ORNBV
LISTED
HEL
Orion Research Foundation grants EUR 1,109,000 for research in 2025
News Preview
Orion Research Foundation grants EUR 1,109,000 for research in 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
21.11.2024
AMRX
LISTED
NASDAQ
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced the advancement of two key strategic initiatives. First, the Company has resubmitted to the U.S. Food and Drug Administration (FDA) its new drug application (NDA) for dihydroergotamine (DHE) prefilled syringe autoinjector for t...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.11.2024
GMAB
LISTED
CPH
Grant of Restricted Stock Units and Warrants to Employees in Genmab
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
21.11.2024
ZLAB
LISTED
NASDAQ
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)
News Preview
Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for the novel antibacterial drug XACDURO® (sulbactam-durlobactam) in mainland China. Pfizer’s affiliated companies will be exclusively authorized to undertake and perform certain commercialization activities for XACDURO® in main...
Themefolio
Profiler
Peergroup
© PR Newswire
21.11.2024
SECT_B
LISTED
STO
RSNA 2024 spotlight: Sectra showcases how radiologists can gain increased diagnostic throughput without working more hours
News Preview
LINKÖPING, Sweden, Nov. 21, 2024 /PRNewswire/ -- At this year's Radiological Society of North America's annual meeting (RSNA), international medical imaging IT and cybersecurity company Sectra (STO: SECT B) will showcase its latest developments to make the radiologists' workflows faster. By providing all essential diagnostic tools in one applicat...
Themefolio
Profiler
Peergroup
© PR Newswire
21.11.2024
SECT_B
LISTED
STO
RSNA 2024 spotlight: Sectra showcases how radiologists can gain increased diagnostic throughput without working more hours
News Preview
LINKÖPING, Sweden, Nov. 21, 2024 /PRNewswire/ -- At this year's Radiological Society of North America's annual meeting (RSNA), international medical imaging IT and cybersecurity company Sectra (STO: SECT B) will showcase its latest developments to make the radiologists' workflows faster. By providing all essential diagnostic tools in one applicat...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.11.2024
IBAB
LISTED
EURONEXT
IBA Business Update – Third Quarter 2024
News Preview
Louvain-la-Neuve, Belgium, 21 November 2024 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its business update for the third quarter ending 30 September 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2024
MURA
LISTED
NASDAQ
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
News Preview
Nemvaleukin was generally well tolerated in ARTISTRY-1, a completed phase 1/2 clinical trial, with durable responses observed in both monotherapy and combination therapy across a range of heavily pretreated advanced solid tumors, including in platinum-resistant ovarian cancer (PROC), which does not typically respond to immunotherapies...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2024
RXRX
LISTED
NASDAQ
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
News Preview
SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The business combination of two AI-powered drug discovery and development companies, Recursion (Nasdaq: RXRX) and Exscientia has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion creating a vertically-integrated and technology-enabled drug discovery platform. Exscient...
Themefolio
Profiler
Peergroup
© BusinessWire
19.11.2024
EHAB
LISTED
NYSE
Enhabit Announces Participation in Upcoming BofA Home Care Conference
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its participation in the upcoming BofA Securities 2024 Home Care Conference.
Enhabit’s President and Chief Executive Officer Barb Jacobsmeyer, incoming Chief Financial Officer Ryan Solomon, and Senior Vice President of Strategic Finance & Treasurer Jobie...
Themefolio
Profiler
Peergroup
© PR Newswire
19.11.2024
INDV
LISTED
NASDAQ
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024
News Preview
Data show rapid initiation with once-monthly SUBLOCADE significantly improves retention in opioid use disorder (OUD) patients, especially among fentanyl-positive participants. Study also administered second SUBLOCADE injection a week later vs. standard 28 days, enabling patients to achieve and maintain target medication levels more quickly.Presen...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.11.2024
ORNBV
LISTED
HEL
Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies
News Preview
ORION CORPORATION INVESTOR NEWS 19 NOVEMBER 2024 at 18.30 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.11.2024
KDEV
LISTED
STO
Karolinska Development's portfolio company Modus Therapeutics secures bridge financing
News Preview
STOCKHOLM, SWEDEN November 19, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Modus Therapeutics has secured access to bridge financing of up to SEK 5 million from Karolinska Development, the company’s largest shareholder. The funding enables Modus to initiate the recently approved phase 2a study...
Themefolio
Profiler
Peergroup
© BusinessWire
19.11.2024
SLP
LISTED
NASDAQ
Simulations Plus to Participate in the BTIG Digital Health Forum
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, today announced that Shawn O’Connor, chief executive officer, will participate in the virtual BTIG Digital Health Forum on Monday, November...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
